A small subset of AML patients (two cases in our cohort and a small subset of AML cases in other two studies [10, 11]) had a high level of 2HG, yet no IDH mutation was identified by employing moderately high sensitivity molecular assays including NGS. The gene discussed is IDH2; the disease is acute myeloid leukemia.